533 related articles for article (PubMed ID: 21851268)
1. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
3. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
4. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
Planas R; Pujol-Borrell R; Vives-Pi M
Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
[TBL] [Abstract][Full Text] [Related]
6. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
[TBL] [Abstract][Full Text] [Related]
8. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
11. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
12. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
13. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
[TBL] [Abstract][Full Text] [Related]
14. 'Sensing' autoimmunity in type 1 diabetes.
Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
16. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
17. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
18. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice.
Cvjetićanin T; Miljković D; Stojanović I; Dekanski D; Stosić-Grujicić S
Br J Nutr; 2010 May; 103(10):1413-24. PubMed ID: 20025835
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
[TBL] [Abstract][Full Text] [Related]
20. Rehabilitation of adaptive immunity and regeneration of beta cells.
Pasquali L; Fan Y; Trucco M; Ringquist S
Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]